Showing 20,121 - 20,140 results of 31,834 for search '(( 50 ((((mean decrease) OR (nn decrease))) OR (a decrease)) ) OR ( 5 fold decrease ))', query time: 1.02s Refine Results
  1. 20121

    Supplemental_Figure_of_Imeglimin_ameliorate_SA-AKI by Hiroyasu Goto (12227927)

    Published 2025
    “…Data are presented as the mean ± SE. Data were analyzed using a two-way analysis of variance (ANOVA) with Šidák’s post-hoc test #p<0.05. …”
  2. 20122

    Effect of environmental factors on the germination of Megathyrsus maximus: an invasive weed in sugarcane in Argentina by Debora C. Cabrera (10460723)

    Published 2021
    “…Both mean germination percentages and CG decreased as osmotic potential became increasingly negative (0 MPa to -0.6 MPa), and as sodium chloride solution concentrations increased (10 to 130 mmol L-1). …”
  3. 20123

    The effects of purmorphamine and Msi1 knockdown on p21<sup>CIP1,WAF1</sup> and c-Myc expression. by In-Sun Hong (284033)

    Published 2013
    “…Purmorphamine treatment decreased and increased the expression of p21<sup>CIP1,WAF1</sup> (<b>A</b>) and c-Myc (<b>B</b>), respectively. …”
  4. 20124

    Metabolic reprogramming in <i>dcerk<sup>1</sup></i> mutants. by Niraj K. Nirala (424266)

    Published 2013
    “…Gene expression analysis revealed 152 genes were increased (2-fold or more) and 158 genes were decreased (0.5 fold or less) in <i>dcerk<sup>1</sup></i> compared to <i>w<sup>1118</sup></i>. …”
  5. 20125
  6. 20126
  7. 20127
  8. 20128
  9. 20129
  10. 20130
  11. 20131
  12. 20132

    Astilbin exerts anti-hypersensitivity by regulating metabolic demand and neuronal activity in rodent model of neuropathic pain by Qiru Wang (12260453)

    Published 2024
    “…</p> <p>In experiments conducted on neuropathic rats, both systemic and intrathecal administration of astilbin, an essential constituent, exhibited a noteworthy and dose-dependently decrease in chronic and acute pain behaviours. …”
  13. 20133

    Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts by Li Liu (75607)

    Published 2012
    “…The current study evaluated the vascular-disrupting activity of BPR0L075 in human breast cancer mammary fat pad xenografts using dynamic bioluminescence imaging. A single dose of BPR0L075 (50 mg/kg, intraperitoneally (i.p.)) induced rapid, temporary tumor vascular shutdown (at 2, 4, and 6 hours); evidenced by rapid and reproducible decrease of light emission from luciferase-expressing orthotopic MCF7 and MDA-MB-231 breast tumors after administration of luciferin substrate. …”
  14. 20134
  15. 20135
  16. 20136
  17. 20137
  18. 20138
  19. 20139
  20. 20140